Global Polyglycolic Acid Suture Market Size By Type (75cm, 90cm), By Application (Human Application, Veterinary Application), By Region, And Segment Forecasts, 2023 to 2032

The Global Polyglycolic Acid (PGA) Suture Market was valued at USD 890 million in 2023 and is projected to reach USD 1.55 billion by 2031, expanding at a CAGR of 7.2% during the forecast period from 2023 to 2031. The market is experiencing strong growth due to the increasing number of surgical procedures globally, growing preference for absorbable sutures, and advancements in suture manufacturing technologies. Polyglycolic acid sutures, known for their high tensile strength and predictable absorption rates, are widely used in internal surgical procedures such as gastrointestinal, gynecological, and cardiovascular surgeries.

Drivers:

1. Rising Number of Surgical Procedures:

An increase in elective and emergency surgeries worldwide, driven by aging populations and lifestyle-related diseases, is fueling the demand for absorbable sutures like PGA sutures.

2. Preference for Biodegradable Materials:

PGA sutures offer biodegradability and eliminate the need for suture removal, reducing patient follow-up visits. This is a major factor influencing their widespread adoption.

3. Technological Innovations in Suture Design:

Ongoing R&D in polymer chemistry and manufacturing techniques is enhancing suture strength, absorption control, and antimicrobial properties, boosting market expansion.

Restraints:

1. High Cost of Advanced Sutures:

Compared to traditional non-absorbable options, PGA sutures are more expensive, which can restrict their use, particularly in cost-sensitive markets.

2. Risk of Allergic Reactions in Some Patients:

Although rare, hypersensitivity or foreign body reactions to synthetic sutures may limit their universal adoption in certain patient groups.

Opportunity:

1. Increasing Demand in Emerging Economies:

Rapidly growing healthcare infrastructure in countries like India, Brazil, and Indonesia presents vast opportunities for market expansion as more hospitals adopt modern surgical practices.

2. Expanding Use in Veterinary and Dental Surgery:

The rising application of PGA sutures beyond human medicine—such as in veterinary procedures and oral surgeries—adds new revenue streams for manufacturers.

Market by System Type Insights:

Based on product type, braided polyglycolic acid sutures dominated the market in 2023. Their superior knot security, minimal tissue reactivity, and ease of handling make them preferable in various surgical specialties. However, monofilament variants are gaining traction in applications where minimal tissue drag is essential, such as ophthalmic and cardiovascular surgeries.

Market by End-use Insights:

In 2023, hospitals emerged as the largest end-use segment, accounting for over 60% of the market share. Hospitals continue to be the primary sites for surgical interventions, benefitting from streamlined procurement of surgical materials. Ambulatory surgical centers (ASCs) are expected to witness the fastest growth during the forecast period due to increasing outpatient procedures and cost-effectiveness.

Market by Regional Insights:

North America led the global market in 2023, supported by robust healthcare systems, high surgical volumes, and early adoption of advanced medical materials. Asia-Pacific is poised to grow at the fastest rate, driven by a surge in healthcare investments, rising medical tourism, and increasing awareness about surgical safety and recovery protocols in emerging countries.

Competitive Scenario:

Leading players in the Global Polyglycolic Acid Suture Market include Johnson & Johnson (Ethicon), B. Braun Melsungen AG, Medtronic plc, Smith & Nephew plc, Sutures India Pvt. Ltd., Peters Surgical, Dolphin Sutures, Teleflex Incorporated, DemeTech Corporation, and Surgical Specialties Corporation. Companies are focused on expanding their product portfolios, entering strategic partnerships, and launching antimicrobial and fast-absorbable variants to differentiate their offerings.

Scope of Work – Global Polyglycolic Acid Suture Market

Report Metric Details

Market Size (2023) USD 890 million

Projected Market Size (2031) USD 1.55 billion

CAGR (2023–2031) 7.2%

Market Segments By System Type (Braided, Monofilament), By End-use (Hospitals, ASCs, Clinics), By Region

Growth Drivers Increase in surgical procedures, rising preference for biodegradable sutures, innovations in polymer science

Opportunities Emerging markets, expanding applications in veterinary and dental surgery

Key Market Developments:

2023: Johnson & Johnson’s Ethicon division launched a new antimicrobial polyglycolic acid suture line to combat surgical site infections.

2024: Dolphin Sutures expanded distribution to Southeast Asian markets, targeting growing demand for absorbable sutures.

2025: Smith & Nephew introduced a high-speed absorption suture designed for rapid-healing surgical procedures in outpatient settings.

FAQs:

1) What is the current market size of the Global Polyglycolic Acid Suture Market?

The market was valued at USD 890 million in 2023.

2) What is the major growth driver of the Global Polyglycolic Acid Suture Market?

The primary growth driver is the rising volume of surgical procedures globally and increasing adoption of absorbable sutures.

3) Which is the largest region during the forecast period in the Global Polyglycolic Acid Suture Market?

North America held the largest market share in 2023.

4) Which segment accounted for the largest market share in Global Polyglycolic Acid Suture Market?

The braided suture segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Polyglycolic Acid Suture Market?

Key players include Johnson & Johnson (Ethicon), Medtronic, B. Braun, Smith & Nephew, and Dolphin Sutures.